BHVNSMALL

Biohaven Ltd.

HealthcareBiotechnology
$13.57
$0.00(-0.37%)
52W$7.48
$18.57
Updated Jun 22, 02:00 AM
RSI71
RS Rating76/99
Beta1.31
Volatility92%
F-Score2/9
Mkt Cap$1.4B
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

Biohaven Ltd. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is moderate (RS Rating: 76), indicating performance broadly in line with the market. Earnings growth of 59% provides fundamental context to the price action. However, price is extended 32% above the 50-day line, increasing the risk of a mean reversion.

Relative Strength
76
out of 99
Average
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
1.31
vs S&P 500
ABOVE MKT
52W Position
55%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$10.28
50 SMA > 100 SMA$10.39
100 SMA > 150 SMA$10.48
150 SMA > 200 SMA$11.57

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$11.17+21.45%ABOVE
50 SMA$10.28+32.02%ABOVE
100 SMA$10.39+30.64%ABOVE
150 SMA$10.48+29.48%ABOVE
200 SMA$11.57+17.31%ABOVE

Price Performance

1D-0.4%
1W+19.3%
1M+59.8%
3M+49.3%
6M+21.9%
YTD+25.2%
1Y-5.7%
3Y-17.1%
52-Week Trading Range55% from low
$13.57
52W Low$7.48
52W High$18.57

Technical Indicators

RSI (14)OVERBOUGHT
71.0
305070
Setup ScoreCOOL
3/10
Base depth: 45.7%

Risk Profile

Beta
1.31
52W Vol
92%
ATR
$0.99
Max DD (1Y)
-57%

Volume Analysis

Today
5.06M
50D Avg
2.38M
Vol Ratio
2.12x
Liquidity
MODERATE

Earnings Momentum

Q2'25+47%
$-1.94
Q3'25+4%
$-1.64
Q4'25+35%
$-1.21
Q1'26+59%
$-0.88
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+39.42%

Stock Price CAGR

10 Years:+6.40%
5 Years:+13.20%
3 Years:-17.10%
1 Year:-5.70%

Return on Equity

10Y Avg:-227.6%
5Y Avg:-204.7%
3Y Avg:-198.0%
Last Year:-866.5%

Key Metrics

Market Cap$1.4B
Gross Margin
Net Margin
Piotroski F-Score2/9

Frequently Asked Questions

Is BHVN in an uptrend right now?

BHVN has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is BHVN overbought or oversold?

BHVN's RSI (14) is 71. The stock is in overbought territory (RSI > 70), which may signal a pullback.

Is BHVN outperforming the market?

BHVN has a Relative Strength (RS) Rating of 76 out of 99. BHVN is performing about average compared to the market.

Where is BHVN in its 52-week range?

BHVN is trading at $13.57, which is 73% of its 52-week high ($18.57) and 55% above its 52-week low ($7.48).

How volatile is BHVN?

BHVN has a Beta of 1.31 and 52-week volatility of 92%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.